Relationship Graph Explorer
Follow the connections
Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.
🌿
Herb
6,826
→
⚗️
Ingredient
44,598
→
🧬
Gene Target
15,695
→
🏥
Disease
30,467
→
🧪
Evidence
23,295
trials · metas · refs
Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient
Urolithin a
3
Clinical Trials
2
Meta-Analyses
0
PubMed References
Top Conditions Studied with Urolithin a
📋 Sample Trials
NCT05921266
Urolithin A Supplementation in Middle-aged Adults With Obesity
Recruiting
NCT05735886
Urolithin A Supplementation to Boost Immune Health
Completed
NCT05814705
The Effects of Protein Supplementation With or Without Urolithin A During Single-leg Immobilization
Active_Not_Recruiting
📊 Sample Meta-Analyses
CRD42022357020
A systematic review of the performance of gut bacteria in the conversion of Urolithin A from its dietary precursors
This study focuses on the mechanisms of action on how urolithin A is developed i
CRD42022377812
Targeting aging with urolithin A in humans: A systematic review and meta-analysis
The severity of age-related physiological changes and the incidence of diseases.
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Urolithin a
⚗️ Identity
Name
Urolithin a
Aliases / Synonyms
1143-70-0; 3,8-dihydroxy-6H-benzo[c]chromen-6-one; 3,8-Dihydroxyurolithin; 3,8-dihydroxybenzo[c]chromen-6-one; 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-; 3,8-Hydroxydibenzo-alpha-pyrone; 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one; ILJ8NEF6DT; Uro-A
🧪 Chemistry
Molecular Weight
228.2030
LogP
2.3574
Drug-likeness
0.457
H-Bond Acceptors
4
H-Bond Donors
2
🔬 Structures
Canonical SMILES
C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O
Isomeric SMILES
C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O
InChIKey
RIUPLDUFZCXCHM-UHFFFAOYSA-N
InChI
InChI=1S/C13H8O4/c14-7-1-3-9-10-4-2-8(15)6-12(10)17-13(16)11(9)5-7/h1-6,14-15H
🔗 External References
🔍 Raw view — every non-empty column on this row (29 fields)
name
Urolithin a
common names
1143-70-0; 3,8-dihydroxy-6H-benzo[c]chromen-6-one; 3,8-Dihydroxyurolithin; 3,8-dihydroxybenzo[c]chromen-6-one; 6H-Dibenzo[b,d]pyran-6-one, 3,8-dihydroxy-; 3,8-Hydroxydibenzo-alpha-pyrone; 3,8-Dihydroxy-6H-dibenzo(b,d)pyran-6-one; ILJ8NEF6DT; Uro-A
herb ingredient id
HBIN047592
canonical smiles
C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O
isomeric smiles
C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O
inchi
InChI=1S/C13H8O4/c14-7-1-3-9-10-4-2-8(15)6-12(10)17-13(16)11(9)5-7/h1-6,14-15H
inchikey
RIUPLDUFZCXCHM-UHFFFAOYSA-N
mol wt
228.2030
num h acceptors
4
num h donors
2
mol logp
2.3574
num rotatable bonds
0
drug likeness
0.457
tcmid ingredient id
27193
pubchem cid
5488186
drugbank id
DB15464
npass id
NPC131766
🏥 Linked Health Topics
1 · diseases via target pathways📋 Clinical Trials
3 · subject of clinical studyNCT05921266 Urolithin A Supplementation in Middle-aged Adults With Obesity
→ Obesity|Vascular Dementia|Cognitive Impairment
NCT05735886 Urolithin A Supplementation to Boost Immune Health
→ Aging
NCT05814705 The Effects of Protein Supplementation With or Without Urolithin A During Single
→ Healthy|Muscle Disuse Atrophy
📊 Meta-Analyses
2 · systematic reviewCRD42022357020 A systematic review of the performance of gut bacteria in the conversion of Urol
→ This study focuses on the mechanisms of action on
CRD42022377812 Targeting aging with urolithin A in humans: A systematic review and meta-analysi
→ The severity of age-related physiological changes
How relationships are computed
- Clinical Trials / Meta-Analyses / References: direct foreign-key link via
subject_entity_id(Phase 2d wireup) - Formula ↔ Herbs: text bridge via
formulas.herbs_in_pinyinmatchingherbs.pinyin_name - Herb ↔ Ingredient:
ACTIVE — direct link via
herb_ingredients - Ingredient ↔ Target:
ACTIVE — direct link via
ingredient_targets - Target ↔ Disease:
ACTIVE — direct link via
target_health_topics - Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables